MIT spinout Infinite Cooling has raised $12.3m in a series A round led by Material Impact.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Third Rock Ventures has led a series A round for Abata Therapeutics, launched by the firm to commercialise research from Harvard, MIT, Johns Hopkins, NIH and UZH.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Harvard-aligned venture capital firm Xfund has reinvested in ImmuneID, which is developing precision immunology therapies based on Harvard University and Johns Hopkins University research.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

MIT mRNA therapeutics spinout Strand has secured series A funding from BeiGene, Redmile Group, Camford Capital, Playground Global and Anri.

Theodorus has contributed to a $23.8m series A round for NeuVasQ, the neurological disease drug developer spun out of Université libre de Bruxelles.

Wake Forest University spinout Renovo closed the round at $6.4m and will put the funding into further development of its brain injury treatment system.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.